UH Seidman Cancer Center appoints division chief and director of immunotherapy center


We have not been able to process your request. Please try again later. If you continue to have this problem, please contact [email protected]

Koen van Besien, MD, PhD, was appointed chief of the division of hematology at the Seidman Cancer Center teaching hospitals.

He will also serve as director of the Wesley Center for Immunotherapy, which generates chimeric antigen receptor T cell therapies, natural killer cell therapies and other cell therapies.

His appointment is effective July 15.

Koen van Besien, MD, PhD

Koen van Besien

Van Besien is recognized for his contributions to the fields of cell therapy and stem cell transplantation. His group reported the first successful transplant for a patient with HIV and leukemia using a haplo-cord transplant. The patient remained HIV and leukemia free for more than 4 years after the transplant.

Previously, he was director of the stem cell transplant program and attending physician at NewYork-Presbyterian Hospital, as well as a professor of medicine at Weill Cornell Medical College.

Van Besien was on the faculty at the University of Texas MD Anderson Cancer Center. He also directed transplant programs at the University of Illinois and the University of Chicago.

Comments are closed.